PharmiWeb.com - Global Pharma News & Resources
04-Dec-2018

Global Sepsis Therapeutics Market 2019-2023 - Leading Players are Akorn, Baxter, Fresenius, Novartis, and Pfizer - ResearchAndMarkets.com

The "Global Sepsis Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.


The Global Sepsis Therapeutics Market is forecast to grow at a CAGR of 5.41% during the period 2019-2023. One trend affecting this market is the strategic alliances. There are several pharmaceutical companies working together for the development of medications for the treatment of sepsis. These alliances will increase the research toward the development of new drugs for the management of sepsis.

According to the report, one driver influencing this market is the high prevalence of sepsis. The rising prevalence of sepsis is expected to fuel the growth of the global sepsis therapeutics market.

Further, the report states that one challenge affecting this market is the product withdrawals. The global sepsis therapeutics market has an acute lack of approved therapies, resulting in huge unmet needs among sepsis patients and hampering the growth of the market.

Key Vendors

  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Market Landscape

4. Market Sizing

5. Five Forces Analysis

6. Customer Landscape

7. Market Segmentation by Product

8. Geographic Landscape

9. Decision Framework

10. Drivers and Challenges

11. Market Trends

12. Vendor Landscape

13. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/lz98xc/global_sepsis?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181204005468/en/

Editor Details

Last Updated: 04-Dec-2018